MBX Share Price
NASDAQ: MBX | Small Cap | HealthcareMBX Stock Performance
MBX Share Price Today
As of 19 November 2026, MBX Biosciences, Inc.'s share price is $53.40. The stock opened at $53.95, compared to its previous close of $52.97. During today's trading session, MBX Biosciences, Inc.'s share price traded between $52.61 and $55.13, with an average price of $53.87. Over the past 52 weeks, the stock has recorded a high of $71.83 and a low of $25.36. In terms of performance, MBX Biosciences, Inc.'s share price has risen by 69.42% over the last six months and is up 54.87% on a year-on-year basis.
MBX Share Price Chart
About MBX
MBX Biosciences Inc is a clinical stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders. The company designed its proprietary Precision Endocrine Peptide, or PEP, platform to overcome the key limitations of unmodified and modified peptide therapies to improve clinical outcomes and simplify disease management for patients. Its PEPs are selectively engineered to have optimized pharmaceutical properties, including extended time-action profiles and consistent drug concentrations with low peak-to-trough concentration ratios, consistent exposure to target tissues, and less frequent dosing. Its product candidates include canvuparatide (MBX 2109), imapextide (MBX 1416), and MBX 4291.
MBX Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $56.69 | $53.37 | -4.35% |
Oct 2026 | $57.76 | $55.80 | -4.84% |
Sep 2026 | $61.95 | $58.63 | -12.01% |
Aug 2026 | $65.69 | $66.63 | +1.02% |
Jul 2026 | $55.40 | $65.96 | +19.54% |
Jun 2026 | $31.57 | $55.18 | +75.06% |
May 2026 | $30.48 | $31.52 | +4.25% |
Apr 2026 | $31.21 | $30.23 | +1.21% |
Mar 2026 | $31.99 | $29.88 | -8.02% |
Feb 2026 | $38.31 | $32.48 | -11.86% |
Jan 2026 | $31.28 | $36.85 | +16.71% |
Dec 2025 | $34.04 | $31.57 | -8.43% |